Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DASATINIB vs ERLOTINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DASATINIB vs ERLOTINIB: Safety Overview

Metric DASATINIB ERLOTINIB
Total FAERS Reports 30,019 22,472
Deaths Reported 2,681 6,791
Death Rate 8.9% 30.2%
Hospitalizations 6,437 3,693
Average Patient Age 56.4 yrs 67.2 yrs
% Female Patients 51.9% 59.8%
FDA Approval Date Apr 22, 2025 Apr 16, 2020
Manufacturer Zydus Pharmaceuticals USA Inc. Zydus Lifesciences Limited
Route ORAL ORAL
Marketing Status Prescription Discontinued